Original Research
Published on 30 May 2025
D-cycloserine effects on COPD and depression in a murine experimental model
in Respiratory Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1554337
- 586 views
Type at least 3 characters
628 articles
Review
Published on 30 May 2025
Current advancements in the mechanisms and animal models of acute exacerbation of pulmonary fibrosis: a systematic review
in Respiratory Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1501085
- 919 views
Review
Published on 21 May 2025
Modulating mitochondria with natural extract compounds: from bench to clinical therapeutic opportunities for COPD
in Respiratory Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1531302
- 1,456 views
Original Research
Published on 20 May 2025
Longitudinal relationships between serum ferritin and prognosis among severe community-acquired pneumonia patients
in Respiratory Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1556185
- 706 views
Original Research
Published on 16 May 2025
Uncovering the mechanism of resveratrol in the treatment of asthma: a network pharmacology approach with molecular docking and experimental validation
in Respiratory Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1596737
- 1,420 views
Original Research
Published on 14 May 2025
Roles of oral anticoagulant use on the risk of 28-day mortality and in-hospital mortality in patients with acute respiratory distress syndrome
in Respiratory Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1565312
- 655 views
Original Research
Published on 12 May 2025
Triglyceride-glucose index as an independent predictor of mortality in patients with chronic respiratory diseases
in Respiratory Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1474265
- 1,054 views
Original Research
Published on 08 May 2025
Prophylactic anticoagulant therapy is associated with improved survival in ICU patients with non-COVID-19 pneumonia: a retrospective cohort study
in Respiratory Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1597885
- 1,108 views
Original Research
Published on 02 May 2025
Benzyl isothiocyanate provokes senolysis by targeting AKT in senescent IPF fibroblasts and reverses persistent pulmonary fibrosis in aged mice
in Respiratory Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1506518
- 1,560 views
Original Research
Published on 28 Apr 2025
Androgen receptor inhibitor ameliorates pulmonary arterial hypertension by enhancing the apoptosis level through suppressing the Notch3/Hes5 pathway
in Respiratory Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1572489
- 1,025 views
Correction
Published on 24 Apr 2025
Corrigendum: Targeting the PI3K/AKT/mTOR pathway in lung cancer: mechanisms and therapeutic targeting
in Respiratory Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1591443
- 914 views
Original Research
Published on 08 Apr 2025
Sparstolonin B nano-formulation attenuates LPS-induced lung injury
in Respiratory Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1532391
- 1,146 views
Case Report
Published on 04 Apr 2025
Case Report: A case of Felty’s syndrome with initial presentation of pleural effusion and subsequent Escherichia coli pyothorax
in Respiratory Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1529621
- 912 views
- 1 citation
Original Research
Published on 03 Apr 2025
Spiraea prunifolia var. simpliciflora leaves ameliorate inflammatory responses and oxidative stress in PPE/LPS-induced chronic obstructive pulmonary disease mouse model
in Respiratory Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1501731
- 1,680 views
Original Research
Published on 14 Mar 2025
The impact of phthalates on asthma and chronic obstructive pulmonary disease: a comprehensive analysis based on network toxicology and molecular docking
in Respiratory Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1566965
- 2,651 views
- 1 citation
Original Research
Published on 05 Mar 2025
Rutin attenuates bleomycin-induced acute lung injury via miR-9-5p mediated NF-κB signaling inhibition: network pharmacology analysis and experimental evidence
in Respiratory Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1522690
- 1,369 views